US STOCKS-S&P 500 hits record as Actavis rallies
* SunEdison, TerraForm rally on entrance to U.S. wind power market
* German analyst and investor sentiment up in November
* U.S. producer inflation up but underlying trend muted
* Indexes up: Dow 0.2 pct, S&P 0.4 pct, Nasdaq 0.6 pct (Updates prices)
By Rodrigo Campos
NEW YORK, Nov 18 (Reuters) - U.S. stocks rose on Tuesday, lifting the S&P 500 to a record high, boosted by healthcare after Actavis' acquisition of Allergan triggered bullish analyst notes.
Further support for equities came from U.S. producer prices that kept intact a trend of benign inflation and from higher homebuilder sentiment in November, while German analyst and investor sentiment advanced this month for the first time in almost a year.
Allergan on Monday accepted a $66 billion takeover bid from Actavis Plc in cash and stock. At least two analysts raised Actavis' price target, one to as high as $300. Actavis shares rose 6.6 percent Tuesday to $264.38 as the top percentage gainer on the S&P 500.
"There is more space for M&A. Companies are looking for areas to have growth," said Bruce Zaro, chief technical strategist at Bolton Global Asset Management in Boston. Continuación...